Data Foundry

Drug recalls 2023

Norepinephrine 16 mg per 250 mL — Class II drug recall D-0933-2023

Terminated recall by SterRx, LLC, reported 2023-07-26, distributed nationwide. Lack of Assurance of Sterility

Recall numberD-0933-2023
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmSterRx, LLC, Plattsburgh, NY, United States
Recall initiated2023-07-07
Classified2023-07-19
Reported by FDA2023-07-26
Terminated2024-07-08
DistributedNationwide (US)
Quantity92,148 bags
Reason classessterility
NDC70324-0602-01
Lot numbers490097, 490142, 491292, 494442, 496763, 496771, 497408, 497416, 499438, 501032, 501059, 502043, 502051, 503505, 504031, 504250
Expiration dates2023-08-03, 2023-08-10, 2023-08-13, 2023-11-26, 2023-11-30, 2023-12-01, 2023-12-02, 2023-12-03, 2024-01-28, 2024-02-08, 2024-02-15, 2024-03-28, 2024-03-31, 2024-04-04, 2024-04-07, 2024-04-19

Product

Norepinephrine 16 mg per 250 mL (64 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per carton, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-602-01.

Reason for recall

Lack of Assurance of Sterility

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0933-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.